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Abstract
Evidence from observational studies indicates that endometriosis and depression often cooccur. However, conflicting evidence exists, and the etiology as well as biological mechanisms
underlying their comorbidity remain unknown. Utilizing genome-wide association study
(GWAS) data, we comprehensively assessed the relationship between endometriosis and
depression. Single nucleotide polymorphism effect concordance analysis found a significant
genetic overlap between endometriosis and depression (PFsig-permuted = 9.99 × 10-4). Linkage
disequilibrium score regression analysis estimated a positive and highly significant genetic
correlation between the two traits (rG = 0.27, P = 8.85 × 10-27). A meta-analysis of
endometriosis and depression GWAS (sample size = 709,111), identified 20 independent
genome-wide significant loci (P < 5 × 10-8), of which eight are novel. Mendelian randomization
analysis suggests a causal effect of depression on endometriosis. Combining gene-based
association results across endometriosis and depression GWAS, we identified 22 genes with a
genome-wide significant Fisher’s combined P value (FCPgene < 2.75 × 10-6). Genes with a
nominal gene-based association (Pgene < 0.05) were significantly enriched across endometriosis
and depression (Pbinomial-test = 2.90 × 10-4). Also, genes overlapping the two traits at Pgene < 0.1
(Pbinomial-test = 1.31 × 10-5) were significantly enriched for the biological pathways ‘cell-cell
adhesion’, ‘inositol phosphate metabolism’, ‘Hippo-Merlin signaling dysregulation’ and
‘gastric mucosa abnormality’. These results reveal a shared genetic etiology for endometriosis
and depression. Indeed, additional analyses found evidence of a causal association between
each of endometriosis and depression and at least one abnormal condition of gastric mucosa.
Our study confirms the comorbidity of endometriosis and depression, implicates links with
gastric mucosa abnormalities in their causal pathways and reveals potential therapeutic targets
for further investigation.

Keywords: depression, endometriosis, genome-wide association study, molecular genetics,
causal relationship, genetic overlap
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Introduction
Endometriosis is one of the leading gynecological disorders defined by the presence of
endometrial tissues in sites other than within the endometrial cavity (Adamson et al. 2010;
Giudice 2010; Treloar et al. 1999). The disorder continues to be a subject of increasing global
public health importance, affecting approximately 10% of reproductive-aged women, and, up
to 50% of women with infertility or sub-fertility, worldwide (Giudice 2010; Zondervan et al.
2018). Menstrual irregularities, dysmenorrhea, and varying degrees of chronic pelvic pains are
among the most common clinical signs of endometriosis (Laganà et al. 2015; Tripoli et al.
2011). Depression, on the other hand, is a chronic psychiatric illness characterized primarily
by social dysfunction, feelings of guilt or low self-worth, cognitive impairment, loss of- and
changes in sleep, appetite, and libido as well as a substantial deterioration in mood and
behaviors (Lépine and Briley 2011; World Health Organization 2017). Similar to
endometriosis, which is predominantly found in women, depression ranks as the leading cause
of disease burden among women and is associated with increased risks of morbidity and
mortality (Kuehner 2017; Lépine and Briley 2011; Mathers 2008; Rei et al. 2018).
Both endometriosis and depression carry considerable personal, social, as well as economic
burdens on sufferers, their families, and indeed the larger society (Greenberg et al. 2015; Rush
and Misajon 2018). A recent study (Rush and Misajon 2018), for example, reveals that the
personal wellbeing index for women with endometriosis was lower than those reported for
other chronic diseases including cancers and HIV/AIDS (Cummins et al. 2009; Hutton et al.
2013). Similarly, compared to the general population, depressed patients have over 20-fold
increased risks of mortality from suicide (Bachmann 2018; Lépine and Briley 2011; Ösby et
al. 2001). Despite the consistent evidence on the growing global burden of endometriosis and
depression (Chisholm et al. 2016; Lépine and Briley 2011; Rush and Misajon 2018), their
adverse impacts on patients’ quality of life and consequences for higher risks of morbidity,
infertility

(endometriosis)

and

mortality

(depression),

the

two

disorders

remain

underdiagnosed, often misdiagnosed and undertreated, worldwide (Bedaiwy et al. 2017;
Centers for Disease Control and Prevention 2010; Ghai et al. 2020; Lépine and Briley 2011;
Ricky and O’Donnell Siobhan 2017). Also, while several theories have been proposed to
explain the pathogenesis of endometriosis (Burney and Giudice 2012; Sampson 1925; Sourial
et al. 2014) and depression (Gałecki and Talarowska 2018; Hasler 2010), the etiologies of the
two disorders remain relatively obscure. There is currently no sufficient evidence on the
effectiveness of laboratory diagnostic markers for endometriosis or depression just as no
5

known treatment offers curative assurance for any of them (Bedaiwy et al. 2017; Gupta et al.
2016; Marian and Hermanowicz-Szamatowicz 2020; Strawbridge et al. 2018).
Evidence from observational studies indicates that a significant association exists between
endometriosis and depression (Cavaggioni et al. 2014; Lorencatto et al. 2006; Pope et al. 2015).
For example, a study in the United States, found the prevalence of depression to be nearly twofold higher among women with endometriosis than in the general population (6.8% vs 3.9%, P
< 0.001) (Mirkin et al. 2007). Another study reported more than twice the prevalence of
depression in endometriosis cases compared to controls (39.4% vs 18.6%, P = 0.045) in an
Italian population (Cavaggioni et al. 2014). A longitudinal follow-up study similarly found
elevated risks of major depression and any depression among endometriosis patients with
estimated hazard ratios (HR) of 1.56 (95%CI: 1.24–1.97) and 1.44 (95%CI: 1.25–1.65),
respectively (Chen et al. 2016). More recently, another longitudinal study reported
bidirectional relationships between endometriosis and several psychiatric disorders including
depressive disorders (endometriosis as the outcome variable [Adjusted HR = 1.89 (95%CI:
1.78–2.01)]; depressive disorder as the outcome variable [Adjusted HR = 1.81 (95%CI: 1.71–
1.92)]) (Gao et al. 2020). These associations are supported also in animal models; female mice
with induced endometriosis were found to be ‘more depressed’, and ‘anxious compared to
sham controls’ with evidence for gene expression alterations in the brain (Li et al. 2018).
Similar findings were reported in another recent animal study in rats models (Lima Filho et al.
2019). Comorbid depression in endometriosis patients may predispose to disease worsening,
poor prognosis, lower quality of life and increased cost of treatments (Mirkin et al. 2007;
Valderas et al. 2009).
Notwithstanding the number of studies reporting a significant association between
endometriosis and depression, the biological mechanism(s) underlying their possible comorbid
relationship remain(s) unknown. A recent systematic review and meta-analysis of crosssectional studies concluded that the association between endometriosis and depressive
symptoms is largely determined by chronic pain (Gambadauro et al. 2019). The study reported
that i) endometriosis patients with pelvic pain had higher levels of depressive symptoms
compared to endometriosis patients without pelvic pain (Gambadauro et al. 2019), and ii)
women with pelvic pain and endometriosis do not have higher levels of depressive symptoms
compared to women with pelvic pain and no endometriosis. These results are consistent with
the previous finding of when pain is moderate to severe, it is associated with more depressive
symptoms (Bair et al. 2003); and suggest that depressive symptoms are related to chronic pain
6

rather than endometriosis (Gambadauro et al. 2019). However, further interpretation of these
results is limited due to their reliance on cross-sectional data (Gambadauro et al. 2019). Also,
given that both endometriosis and depression are complex disorders, we hypothesize that pain
does not seem plausible for a complete explanation of their potential comorbid relationship.
Moreover, several other studies did not find a significant association between endometriosis
and depressive symptoms (Cavaggioni et al. 2014; Gambadauro et al. 2019; Novais et al. 2018).
Hence, clear, and convincing evidence on the comorbidity, as well as the possible biological
mechanisms underlying endometriosis and depression association is lacking.
With a twin-based heritability (the proportion of variance in phenotypes explained by variance
in genotype) estimate of about 0.50 and single nucleotide polymorphism (SNP)-based
heritability of 0.26, there is strong evidence for a role of genetic factors in the risk of
endometriosis (Kennedy 1999; Lee et al. 2012; Montgomery et al. 2008; Simpson and Bischoff
2002; Stefansson et al. 2002). Similarly, consistent evidence supports the contribution of
genetics in the development of depression (Levinson 2006; Ripke et al. 2013), with a twinbased heritability estimate of 0.31–0.42 (Sullivan et al. 2000). Indeed, several genome-wide
association studies (GWAS) have been conducted and an increasing number of SNPs, as well
as susceptibility loci, are being identified for both endometriosis and depression (Howard et al.
2019; Sapkota et al. 2017; Wray et al. 2018). No study has, however, leveraged on the possible
pleiotropy of genetic variants among the two disorders as a basis for the discovery of new
susceptibility loci shared by both endometriosis and depression. Furthermore, studies with a
specific focus on the mechanism of association between endometriosis and depression, using
the molecular genetic study approach, are lacking.
Therefore, we comprehensively assessed the genetic relationship between endometriosis and
depression by analyzing large population-based GWAS data. The approaches used in this study
minimize the challenges often associated with the conventional observational studies such as
small sample sizes, the bias of reverse causation and the confounding influence of
environments or lifestyles. Moreover, analysis of such molecular genetic data offers a unique
opportunity to assess not only the shared genetics but also the potential causal associations
between the two traits. Hence, findings in the present study will improve our understanding of
the genetic architecture of the two disorders, as well as provide insights into the mechanisms
of their co-occurrence. This knowledge is expected to contribute to efforts aimed at identifying
druggable targets and subsequently enhance better outcomes for both endometriosis and
depression.
7

Materials and Methods
Our study comprises five broad components. First, we assessed the molecular genetic overlap
and correlation between endometriosis and depression using SNP effect concordance analysis
(SECA) and linkage disequilibrium score regression (LDSC) analysis methods, respectively.
Second, leveraging on the power afforded by pooling GWAS data, we investigated SNPs and
loci shared by the two traits using cross-disorder meta-analysis of GWAS. Third, utilizing
Mendelian randomization (MR), we assessed potential causal relationships between
endometriosis and depression. Fourth, to identify genes shared by endometriosis and
depression as well as assess gene-level genetic overlap, we performed gene-based association
studies and independent gene-based test. Lastly, to gain mechanistic insights into the biology
of the two disorders, we investigated biological pathways shared by endometriosis and
depression using pathway-based functional enrichment analysis method.
Data sources
GWAS summary statistics data sourced from large international consortia including the
International Endogene Consortium (IEC, endometriosis GWAS data) (Sapkota et al. 2017)
and the Psychiatric Genomics Consortium (PGC, PGC_UKB depression GWAS data) were
utilized for analyses in the present study. There is no sample overlap between these two GWAS
data; hence, limitations associated with overlap of samples do not apply in our study.
IEC Endometriosis GWAS data
The ‘IEC endometriosis’ GWAS summary statistics data analyzed in this study have been well
described in previous studies (Adewuyi et al. 2020; Sapkota et al. 2017). In brief, the data
consist of a total sample of 208,912 individuals (17,054 cases of endometriosis and 191,858
controls), and 6,979,035 SNPs (that passed quality control in at least 50% of the studies),
representing the largest GWAS published to date in the genetic study of endometriosis (Sapkota
et al. 2017). The ‘IEC endometriosis’ GWAS data combined 11 separate GWA case-control
data sets as previously described in Sapkota et al. (2017). Similar quality control (QC)
procedures were applied in each of the individual datasets and study participants were of
European (93%) and Japanese (7%) ancestry from Australia, Iceland, Belgium, the UK, the
USA, Denmark and Japan (Sapkota et al. 2017).
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Depression GWAS data
The ‘2019 PGC_UKB Depression Genome-wide’ summary data (‘PGC_UKB depression’
GWAS

data)

analyzed

in

our

study

were

obtained

from

the

PGC

(https://www.med.unc.edu/pgc/). The ‘PGC_UKB depression’ GWAS combines two large
depression data sourced from the PGC and the United Kingdom Biobank (UKB). The PGC
components of the data comprise of a meta-analysis of 33 cohorts (excluding the 23andMe and
the UKB data) and have been previously described (Wray et al. 2018). The second component
of the ‘PGC_UKB depression’ GWAS data was obtained from the UKB broad depression
phenotype described in (Howard et al. 2019). Together, the PGC_UKB depression’ GWAS
data consist of a total sample of 500,199 individuals (170,756 cases of depression and 329,443
controls), of European ancestry, and a total of 8,483,301 SNPs.
To test the reproducibility of our study, we utilized two additional depression datasets—the
2018 major depressive disorder (MDD) GWAS and the self-reported depression GWAS,
sourced from the PGC and the UKB, respectively. The 2018 MDD GWAS comprised of
135,458 cases and 344,901 controls (Wray et al. 2018). Of these, 75,607 cases and 231,747
controls were obtained from 23andMe. The data utilized in the present study (the ‘PGC 2018
MDD excl23andMe’) excluded the 23andMe data (to avoid sample overlap with the IEC
endometriosis GWAS) and consisted of 59,851 cases, 113,154 controls, and a total of
13,554,551 SNPs. A more comprehensive description of the data has previously been published
(Wray

et

al.

2018).

The

self-reported

depression

UKB

GWAS

data

(https://atlas.ctglab.nl/ukb2_sumstats/20002_1286_logistic.EUR.sumstats.MACfilt.txt.gz)
consist of 289,307 individuals (cases = 22,055, control = 267,252) and 10,321,706 SNPs.
Assessing SNP-level genetic overlap
We assessed the SNP-level genetic overlap between endometriosis and depression using the
standalone version

of

SECA (https://sites.google.com/site/qutsgel/software/seca-local-

version) (Nyholt 2014). We used the default ‘P value informed’ setting of SECA to extract the
subset of independent SNPs overlapping the two GWAS datasets accounting for linkage
disequilibrium (LD) r2 < 0.1. We first assigned the ‘IEC endometriosis’ GWAS as dataset 1
and the ‘PGC_UKB depression’ GWAS as dataset 2 to extract the set of independent SNPs
with the smallest endometriosis GWAS P values. We performed an analogous analysis in
which the ‘PGC_UKB depression’ GWAS was assigned as dataset 1 and the ‘IEC
endometriosis’ GWAS as dataset 2 to analyze the set of independent SNPs with the smallest
9

depression GWAS P values. This procedure enabled us to assess and allow for possible
differences between the two GWAS to detect association at their overlapping SNPs or where
one trait may be more predictive of the other (Adewuyi et al. 2020; Nyholt 2014). Last, we
utilized the ‘PGC 2018 MDD excl23andMe’ and the ‘self-reported depression UKB’ GWAS
in reproducibility testing for the SNP-level genetic overlap between endometriosis and
depression. A more comprehensive description of our SNP-level genetic overlap assessment is
presented in Supplemental Note 1.
Cross-disorder genetic correlation
We estimated the SNP-based heritability as well as examined the genetic correlation between
the ‘IEC endometriosis’ GWAS and the ‘PGC_UKB depression’ GWAS, using the LDSC
method (https://github.com/bulik/ldsc) (Bulik-Sullivan et al. 2015). We performed further
analyses to test the reproducibility of the genetic correlation between endometriosis and
depression using two additional GWAS datasets, the ‘PGC 2018 MDD excl23andMe’ and the
‘self-reported depression UKB’ GWAS. Supplemental Note 1 provides more comprehensive
and specific details of this analysis.
Cross-disorder meta-analysis of endometriosis and depression GWAS
To identify SNPs and loci shared by both endometriosis and depression, we performed a crossdisorder meta-analysis of ‘IEC endometriosis’ and the ‘PGC_UKB depression’ GWAS data.
Complementary models of meta-analysis methods including the inverse variance-weighted
fixed effects (FE), the conventional random effects (RE) and the ‘Han and Eskin’s random
effects’ (RE2) models (Han and Eskin 2011) were utilized in the present study. The FE model
is limited under heterogeneity while the RE is overly conservative. The RE2, a modified RE
model, is optimized for detecting associations even where heterogeneity exists (Han and Eskin
2011).

All

these

models

were

implemented

in

the

METASOFT

software

(http://genetics.cs.ucla.edu/meta) (Han and Eskin 2011). We included a total of 709,111
participants and meta-analyzed 6,694,342 SNPs overlapping the two GWAS datasets.
Identifying SNPs and loci reaching genome-wide significant association (P < 5 × 10-8) in the
meta-analysis, and, associated with both endometriosis and depression GWAS at 5 × 10-8 < P
< 0.05, was the major aim of the present analysis.
Using FUMA (Watanabe et al. 2017), we identified significant independent SNPs alongside
SNPs in LD with them, defined lead SNPs as well as characterized the associated genomic loci
(r2 < 0.1). SNPs reaching genome-wide significant association (P < 5 × 10-8, n = 625) in the
10

cross-disorder meta-analysis but not in the individual endometriosis and depression GWAS (5
× 10-8 < P < 0.05) were used for this analysis. We first identified genome-wide significant
independent SNPs at r2 < 0.6 (that is SNPs that are independent of one another at r2 < 0.6).
From these, lead SNPs, defined as a subset of significant independent SNPs in LD with each
other at r2 < 0.1, were determined. Genomic loci were thereafter characterized with respect to
a physical distance of 250 kb from each lead SNP. In other words, lead SNPs within 250 kb
from each other were merged into the same genomic locus. Hence, more than one independent
or lead SNP may be present in a genomic locus.
Further, we performed gene mapping in which all the SNPs reaching genome-wide significance
were mapped to genes using three gene mapping strategies, implemented in FUMA (Watanabe
et al. 2017). Briefly, SNPs were first annotated with their biological functions and subsequently
linked to genes using the three methods (positional, expression quantitative trait loci [eQTL],
and chromatin interaction) in line with practice in previous studies (Nagel et al. 2018;
Watanabe et al. 2017). Additionally, we performed a gene-based genome-wide association
study (GBGWAS) on the same set of SNPs using MAGMA software (implemented in FUMA).
A detailed description of our cross-disorder meta-analysis, genomic loci characterization, SNP
annotation, and functional gene mapping is provided in Supplemental Note 1.
Association between significant independent SNPs and other traits
We assessed a possible SNP-phenotype association between our independent genome-wide
significant SNPs and other previously published GWAS traits. Specifically, we assessed
whether our independent SNPs were associated with traits previously reported to be associated
with endometriosis or depression. This assessment was carried out using PhenoScanner (v2,
accessed on 07/01/2020) at P < 5 × 10-8) (Staley et al. 2016).
Assessing causal relationships between endometriosis and depression
We assessed a causal relationship between endometriosis (exposure variable) and depression
(outcome

variable)

utilizing

the

two-sample

Mendelian

randomization

analysis

(“TwoSampleMR”) method (https://mrcieu.github.io/TwoSampleMR) (Hemani et al. 2018)
implemented in the R statistical software. To estimate the weighted mean of depression risk
per standard deviation increase in the risk of endometriosis, we utilized the inverse variance
weighted (IVW) MR model in which the effects of the individual IVs were combined (Burgess
et al. 2020). To test the validity of our IVW results, we conducted sensitivity analyses using
the weighted median estimation, the MR-Egger regression, and the MR-PRESSO (Mendelian
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randomization pleiotropy residual sum and outlier) methods (Verbanck et al. 2018). We also
assessed the causal influence of depression on endometriosis in which depression was assessed
as an exposure variable and endometriosis as an outcome variable. Additional details of these
analyses are provided in Supplemental Note 1.
Gene-based association study
To complement our SNP-level genetic overlap analysis across endometriosis and depression
GWAS, and identify genes shared by the two disorders, we performed gene-based association
analyses for the two traits. Unlike the SNP-based study which can be limited by small effect
sizes, allelic heterogeneity and correlation among SNPs, gene-level association analysis
aggregates the effects of multiple SNPs and may provide greater power for identifying risk
variants for a complex trait (Liu et al. 2010; Zhao and Nyholt 2017). The MAGMA software,
implemented in FUMA, was used to perform this analysis (de Leeuw et al. 2015; Watanabe et
al. 2017). A total of 6,694,342 SNPs overlapping the endometriosis and depression GWAS was
used in computing gene-based P values for the respective traits. SNPs were mapped in
MAGMA to a gene if they were located within the gene (i.e., a window of ‘+/- 0kb outside the
gene’) in our analysis. From the results of our MAGMA analysis, we extracted and assessed
genes with P values at Pgene < 0.1 overlapping both traits. To identify shared genome-wide
significant genes for both endometriosis and depression, we combined gene-based association
P values for the two disorders using the Fisher’s Combined P value (FCP) method.
Independent gene-based test
Using the genetic type 1 error calculator (GEC) (Li et al. 2012), we conducted independent
gene-based tests, first to identify the effective number of independent genes, and second to
generate data for assessing the gene-level genetic overlap between endometriosis and
depression. GEC estimates independent markers while accounting for LD and adjusting for
multiple testing corrections (Li et al. 2012). We first performed a gene-based test for
endometriosis and depression using VEGAS2 software. We used ‘ALL’ chromosomes,
restricted gene definition to ‘+/- 0kb outside gene’ and selected sub-population from ‘ALL
EUROPEAN’ in our VEGAS2 gene-based analysis (Adewuyi et al. 2020; Mishra and
Macgregor 2015). Given our aim of performing an independent gene-based test, we specified
the ‘Best-SNP test’ option in our VEGAS2 gene-based analysis (Adewuyi et al. 2020; Mishra
and Macgregor 2015). We processed ‘Best-SNPs’ (index SNPs) obtained in our gene-based
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analysis, for endometriosis and depression, respectively, as input files for GEC. See
Supplemental Note 1 for further details of this analysis.
Assessing gene-level genetic overlap
We assessed whether the proportion of overlapping genes, between endometriosis and
depression, at three nominal P values (Pgene < 0.1, Pgene < 0.05, and Pgene < 0.01) thresholds,
were more than expected by chance. The independent gene-based analyses results were utilized
for this analysis. First, we estimated the effective number of independent genes overlapping
endometriosis and depression at the three-nominal P values. Second, we assigned
endometriosis as the ‘discovery’ and depression as the ‘target’ set; and thereafter, calculated
the proportion of expected as well as observed genes overlapping the two traits. Last, using the
binomial test, we compared the proportion of observed and expected overlapping independent
genes across the three P value thresholds to assess the statistical significance of their respective
differences. In other words, we assessed whether the proportion of overlapping genes observed
were significantly higher than by chance. The expected proportion of overlapping genes was
defined as the effective number of independent genes with a P value less than the threshold in
the target set divided by the total effective number of independent genes in the target set
(Adewuyi et al. 2020; Zhao et al. 2016). The observed proportion of overlapping genes was
calculated as the observed effective number of independent overlapping genes divided by the
effective number of independent genes with a P value less than the threshold in the discovery
set (Adewuyi et al. 2020; Zhao et al. 2016).
Gene-drug targets search
We searched for ‘gene-drug interactions’ and ‘potential targets for drugs’ using the drug-gene
interaction database (DGIdb 3.0, www.dgidb.org, accessed on 24/12/2019) (Cotto et al. 2017;
Griffith et al. 2013). Utilizing genes overlapping endometriosis and depression at Pgene < 0.1 ,
we first searched 20 DGIdb drug-gene source databases to identify interactions with existing
medicines based on 41 gene categories and 51 types of known interactions. We filtered drugs
that interact with our input genes using the following terms or categories: antineoplastic,
immunotherapies and the United States Food and Drug Administration (FDA) approved
pharmaceutical molecules. Moreover, to identify genes for potential therapeutic targets
(druggable targets), we conducted a further search in 10 source databases (implemented in the
DGIdb tool), based on 41 gene categories. A list of overlapping genes having Pgene < 0.1 were
similarly used as an input in the druggable targets search.
13

Pathway-based functional enrichment analysis
We conducted functional enrichment analysis using the ‘g:GOSt’ tool, implemented in the ‘gprofiler’ software (Raudvere et al. 2019; Reimand et al. 2016), to identify significantly enriched
(overrepresented) biological processes and pathways underlying endometriosis and depression.
We utilized the web version of the ‘g:GOSt’ tool (accessed on 15th December 2019) to analyze
genes overlapping endometriosis and depression GWAS at Pgene < 0.1, in the present study. We
applied the recommended ‘g:SCS algorithm’ in multiple testing correction and restricted term
size (functional category) of the significantly enriched pathways to the recommended 5 and
350 values (Adewuyi et al. 2020; Raudvere et al. 2019). By default, the ‘g:GOSt’ software only
reports overrepresented pathways at the adjusted enrichment P value (Padj) < 0.05 (Raudvere
et al. 2019). Given some of the significantly enriched pathways may be redundant, we carried
out enrichment mapping, collapsing related pathways into similar biological themes, and
subsequently enhancing the visualization of overrepresented pathways (Merico et al. 2010;
Reimand et al. 2019). Lastly, to further enhance the interpretation of our results, we organized
‘enrichment maps’ (biological themes of pathways generated using the ‘enrichment mapping’
method) into clusters using the ‘auto annotate’ software (Reimand et al. 2019). The
‘enrichmentmap’ and ‘auto-annotate’ applications were implemented in the Cytoscape
platform (version 3.7.1) (Reimand et al. 2019; Shannon et al. 2003).
Results
SNP-level genetic overlap between endometriosis and depression
The first aspect of this study assessed SNP-level genetic overlap between the endometriosis
and depression GWAS utilizing SECA. Results indicate that a significant genetic overlap, more
than expected by chance, exists between endometriosis and depression. In the primary test for
concordance of effects, all 144 SNP subsets across ‘IEC endometriosis’ and ‘PGC_UKB
depression’ GWAS produced nominally significant concordance of effects (Fisher’s exact test
OR > 1 and P < 0.05)—a result unlikely to have occurred by chance, with a permuted P value
(PFsig-permuted) of 9.99 × 10-4 (95%CI: 5.12 × 10-5–5.64 × 10-3). The most statistically significant
P value for effects concordance (P = 1.04 × 10-19, ORFT = 1.31) was for SNP subsets with P1
≤ 0.3 (endometriosis) and P2 ≤ 0.4 (depression). When the direction of the analysis was
reversed (see methods), the total number of SNP subsets producing nominally significant
concordance effects remained unchanged at 144, further supporting our findings of significant
genetic overlap between the two traits.
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Additional results from SECA reveal that of the total 50,413 independent SNPs (LD
independent [r2 < 0.1]) overlapping both the IEC Endometriosis and the PGC-UKB depression
GWAS, 26,102 (51.8%) SNP effects were significantly concordant across the two traits (OR =
1.13, PFisher’s-exact = 1.36 × 10-11). Notably, and in line with expectation (Table 1), SNP subsets
with smaller P values (P1 and P2) exhibit even greater effect concordance (measured by OR).
For instance, at P < 0.05 (SNP subsets with P1 = P2 < 0.05), 57.8% (1,065) of the 1,844
independent SNPs were concordant (OR = 1.86, PFisher’s-exact = 4.72 × 10-11). The proportion of
effect concordance increased to 66.7% for SNP subsets with P1 = P2 < 0.01 (OR = 3.98,
PFisher’s-exact = 2.67 × 10-7). Reproducibility testing using two separate depression GWAS (the
MDD 2018 and the self-reported UKB depression GWAS) revealed a similar pattern of results
(Supplementary Table S1 and S2). For example, at P1 = P2 < 0.01 (for the ‘IEC endometriosis’
and the ‘PGC 2018 MDD excl23andMe’ GWAS genetic overlap assessment), the OR was 3.95
(PFisher’s-exact = 3.28 × 10-4). Similarly, OR was 3.27 (PFisher’s-exact = 2.14 × 10-3) for the genetic
overlap between the ‘IEC endometriosis’ and the ‘self-reported UKB depression’ at P1 = P2 <
0.01 (Supplementary Table S1 and S2).
Table 1 Genetic overlap between endometriosis and depression
Concordant
SNPs
26,102

Proportion of
concordance
0.52

OR

b

≤1

Total
SNPs
50,413

1.13

1.36 × 10-11

0.9

0.9

45,446

23,502

0.52

1.15

2.88 × 10-13

0.8

0.8

40,343

20,939

0.52

1.17

2.20 × 10-14

0.7

0.7

35,086

18,339

0.52

1.20

2.07 × 10-17

0.6

0.6

29,807

15,656

0.52

1.22

3.27 × 10-18

0.5

0.5

24,608

12,977

0.53

1.24

1.16 × 10-17

0.4

0.4

19,416

10,313

0.53

1.28

4.81 × 10-18

0.3

0.3

14,178

7,596

0.54

1.33

1.85 × 10-17

0.2

0.2

9,022

4,877

0.54

1.38

1.47 × 10-14

0.1

0.1

4,049

2,252

0.56

1.57

9.13 × 10-13

0.05

0.05

1,844

1,065

0.58

1.86

4.72 × 10-11

0.01

0.01

246

164

0.67

3.98

2.67 × 10-7

P1

P2

≤1

a

PFishers-exact

P1: P value for the International Endogene Consortium (IEC) Endometriosis data; P2: P value for the PGC-UKB
depression data; SNP: Single Nucleotide Polymorphism; OR: Odds ratio for the effect direction concordance
association test for endometriosis and depression; PFishers-exact: Fisher’s exact P value for the effect direction
concordance association test between endometriosis and depression. aThere was a total 50,413 independent SNPs
(LD independent [r2 < 0.1]) with smallest P values in the IEC Endometriosis GWAS.
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Genetic correlation between endometriosis and depression
To further assess the SNP-level genetic overlap between endometriosis and depression GWAS,
we examined the correlation between endometriosis and depression using the LDSC software.
Univariate LDSC analysis estimated SNP-based heritability on the liability scale (h2SNP) of
11.44% (95%CI: 10.73–12.15%) for endometriosis and 8.02% (95%CI: 7.77–8.27%) for
depression. Also, bivariate LDSC analysis found a positive and highly significant genetic
correlation (rG) between endometriosis and depression (rG = 0.27, P = 8.85 × 10-27). LDSC
results are provided in Table 2. Notably, we reproduced the significant genetic correlation
between endometriosis and depression using two separate depression GWAS (Table 2).
Table 2 LD Score regression analysis summary
A. SNP-based Heritability
Phenotype
Dataset source
Endometriosis
PGC-UKB depression

MDD
Depression

IEC
PGC-UKB 2019

PGC 2018
UKB

B. SNP-based Genetic Correlation
Phenotype 1
Phenotype 2
(data source)
(data source)
Endometriosis
Depression
(PGC-UKB,
(IEC)
2019)

Endometriosis
(IEC)
Endometriosis
(IEC)

Liability scale h2SNP (95%
CI)
11.44% (10.73–12.15%)
8.02% (7.77–8.27%)

MDD (PGC 2018)

Depression (UKB)

6.93% (6.64–7.22%)
8.25% (7.08–9.41%)
rG (se)
[P value]
0.27 (0.0248)
[8.85 × 10-27]

0.28 (0.0321)
[1.79 × 10-18]
0.21 (0.0476)
[1.10 × 10-5]

Phenotype 1
h2 Intercept
Constrained to
1

Constrained
to 1
Constrained
to 1

h2 Intercept (se)
Constrained to 1
Constrained to 1

0.9945 (0.0087)
Constrained to 1

Phenotype 2
h2 Intercept
Constrained
to 1

0.9945
(specified)
1.0123

Gencov
Intercept
Constrained
to 0

Constrained
to 0
Constrained
to 0

IEC: International Endogene Consortium, PGC: Psychiatric Genomic Consortium, UKB: United Kingdom
BioBank, SNP: Single Nucleotide Polymorphism, h2: heritability, h2SNP: SNP-based heritability, CI: Confidence
Interval, se: Standard error

GWAS meta-analysis results
We performed a cross-disorder meta-analysis of endometriosis and depression GWAS to
identify genome-wide significant SNPs and loci shared by both traits. A total of 625 SNPs was
significant (PSNP < 5×10−8) in the FE model of our cross-disorder meta-analysis
(Supplementary Table S3), all of which were at least nominally significant (P < 0.05), but not
genome-wide significant in the individual endometriosis and depression GWAS (i.e., 5 × 10-8
< P < 0.05). From the 625 SNPs reaching genome-wide significant association, we identified
34 moderately independent (LD r2 < 0.6) SNPs (Table 3A). Of these 34 SNPs, 22 were
characterized as lead SNPs (genome-wide significant SNPs that are independent of one another
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at LD r2 < 0.1). A total of 20 independent genomic loci were characterized as having lead SNPs
at least 250 kb from another lead SNP (i.e., lead SNPs within 250 kb from each other were
merged into the same genomic locus). Thus, the 22 lead SNPs were in 20 genomic loci, with
two loci containing two independent lead SNPs each. Eight of the 20 independent genomic loci
have not previously been reported at a genome-wide level of significance for endometriosis or
depression, thus, they represent novel loci for the two disorders (Table 3A).
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Table 3 Summary of the independent genome-wide significant SNPs and loci for endometriosis and depression GWAS meta-analysis
Independent
SNPs

Loci
index

Lead SNP

Chr

Position
(hg19)

EA

NEA

FE Meta-analysis
OR

Endometriosis

Depression

P value

OR

P value

OR

P value

A. Summary of ‘IEC endometriosis’ and ‘PGC-UKB depression’ GWAS meta-analysis

Nearest
coding
gene/ cytoband

Loci linked with depression index SNPs
rs1395455

1

rs1395455

1

37185190

A

G

1.025

4.09 × 10-8

1.03

4.05 × 10-2

1.024

2.92 × 10-7

CSF3R/ 1p34.3

rs1620977

2

rs1620977

1

72729142

A

G

1.027

1.44 × 10

-8

1.037

2.19 × 10

-2

1.026

1.69 × 10

-7

NEGR1/ 1p31.1

rs12738134

1

197470756

A

T

0.971

1.17 × 10

-8

0.961

2.81 × 10

-2

0.972

1.01 × 10

-7

CRB1/1q31.3

rs1998711

1

197546093

A

T

0.976

1.87 × 10

-9

0.947

6.93 × 10

-5

0.979

4.96 × 10

-7

DENND1B/1q31.3

1

197785420

A

G

1.033

3.54 × 10-10

1.065

2.22 × 10-4

1.030

8.22 × 10-8

DENND1B/1q31.3

rs1553172

1

197818233

A

G

1.023

4.62 × 10

-8

1.053

1.57 × 10

-4

1.020

6.47 × 10

-6

C1orf53/1q31.3

rs35207123

1

197827444

A

C

1.030

3.61 × 10

-8

1.063

5.12 × 10

-4

1.027

2.89 × 10

-6

rs11130182

3

49206767

T

C

0.976

1.84 × 10

-8

0.952

5.87 × 10

-4

0.978

1.22 × 10

-6

KLHDC8B/3p21.31

rs9586

3

49213637

T

C

0.969

2.36 × 10-10

0.939

1.24 × 10-4

0.972

5.06 × 10-8

KLHDC8B/3p21.31

3

49797769

A

G

1.034

3.80 × 10

-10

1.067

2.92 × 10

-4

1.031

6.58 × 10

-8

IP6K1/3p21.31
SCLT1/ 4q28.2
NUDT12/ 5q21.2

rs12121863

3

rs12121863

C1orf53/1q31.3

4

rs9586

rs12512642

5

rs12512642

4

131209887

T

C

1.028

4.93 × 10

-8

1.044

2.71 × 10

-2

1.027

3.48 × 10

-7

rs13164188

6

rs13164188

5

103914523

T

C

1.025

9.21 × 10

-9

1.034

2.37 × 10

-2

1.024

1.32 × 10

-7

6

66559858

A

C

0.974

4.77 × 10-9

0.968

2.46 × 10-2

0.975

5.75 × 10-8

EYS/6q12

6

66595931

A

G

0.976

3.53 × 10

-9

0.960

2.14 × 10

-3

0.978

2.00 × 10

-7

EYS/6q12

6

66623210

C

G

1.029

1.43 × 10

-8

1.040

1.92 × 10

-2

1.027

1.49 × 10

-7

EYS/6q12

6

66646546

A

G

1.025

7.31 × 10

-9

1.030

3.50 × 10

-2

1.025

8.01 × 10

-8

EYS/6q12

6

66999917

T

G

1.031

2.23 × 10-9

1.047

7.67 × 10-3

1.029

5.12 × 10-8

EYS/6q12
HIVEP2/6q24.2

rs9835157

rs10085215

rs9885896,
rs12206488

rs9885896
rs4710557
rs767069

7

rs12206488
rs2328370

8

rs2328370

6

143006706

A

C

1.023

3.21 × 10

-8

1.031

2.55 × 10

-2

1.023

2.48 × 10

-7

rs11561993

9

rs11561993

7

109102855

T

C

1.025

2.28 × 10

-9

1.036

9.25 × 10

-3

1.024

6.77 × 10

-8

DNAJB9/7q31.1

9

11120126

T

G

1.031

3.99 × 10

-8

1.039

4.19 × 10

-2

1.030

2.72 × 10

-7

PTPRD/ 9p24.1-p23

9

11213674

A

T

1.025

8.32 × 10-9

1.027

4.92 × 10-2

1.024

6.61 × 10-8

PTPRD/9p24.1-p23

9

11695224

A

G

0.951

9.48 × 10

-9

0.934

4.65 × 10

-2

0.952

6.28 × 10

-8

TYRP1/9p23

9

31234705

A

T

0.976

2.03 × 10

-9

0.961

8.33 × 10

-3

0.977

5.31 × 10

-7

ACO1/ 9p21.1

11

88910589

C

G

1.024

7.96 × 10-9

1.033

1.77 × 10-2

1.024

1.10 × 10-7

rs72694248
rs1931391

10

rs62553458
rs13299293
rs5021654

11

rs1931391,
rs62553458
rs13299293

18

TYR/11q14.3

rs7933594

12

rs7933594

rs1967203

11

88973201

T

C

1.026

5.67 × 10-9

1.031

3.60 × 10-2

1.026

4.10 × 10-8

TYR/11q14.3

11

89055293

A

G

0.977

3.73 × 10

0.966

2.19 × 10

0.978

5.56 × 10

TYR/11q14.3

-8

-2

-7

Novel Loci
rs6680839

13

rs6680839

1

175902596

T

C

0.975

9.18 × 10-10

0.952

5.24 × 10-4

0.977

1.25 × 10-7

TNR/1q25.1

rs72740410

14

rs72740410

1

191115099

T

C

1.048

1.25 × 10

-8

1.049

7.44 × 10

-2

1.048

6.65 × 10

-8

BRINP3/1q31.1

rs13118306

15

rs13118306

4

15477812

C

G

0.977

3.65 × 10

-8

0.960

3.76 × 10

-3

0.979

1.21 × 10

-6

CC2D2A/4p15.32

rs2134025

16

rs2134025

4

104932297

A

G

1.029

1.02 × 10-8

1.057

4.12 × 10-4

1.026

1.31 × 10-6

TACR3/4q24

rs9347896

17

rs9347896

6

165077749

A

G

1.029

1.32 × 10

-8

1.033

4.56 × 10

-2

1.028

7.80 × 10

-8

C6orf118/6q27

rs11784932

18

rs11784932

8

130095478

A

C

1.026

2.82 × 10

-8

1.057

2.57 × 10

-4

1.023

3.25 × 10

-6

GSDMC/ 8q24.21

rs9538160

19

rs9538160

13

59254159

A

G

0.976

2.71 × 10

-8

0.964

8.96 × 10

-3

0.978

5.17 × 10

-7

PCDH17/ 13q21.1

rs35625885

20

rs35625885

15

96957969

A

G

0.965

1.33 × 10-8

0.953

2.04 × 10-2

0.966

2.10 × 10-7

NR2F2/15q26.2

B. Summary of the meta-analysis of ‘IEC endometriosis’ and ‘PGC 2018 MDD excluding 23andME’ GWAS
rs6808036

1

rs6808036

3

49236439

T

G

1.044

2.49 × 10-8

1.065

4.31 × 10-5

1.037

4.52 × 10-5

CCDC36/ 3p21.31

rs323509

2

rs323509

5

104082179

A

C

1.042

2.15 × 10-8

1.031

3.68 × 10-2

1.046

1.45 × 10-7

NUDT12/ 5q21.2

rs116810322

3

rs116810322

6

30223490

T

C

1.042

9.70 × 10

-9

1.064

4.79 × 10

-5

1.036

1.47 × 10

-5

TRIM26/ 6p22.1

rs1931388

4

rs1931388

9

11203149

A

G

1.039

4.44 × 10

-8

1.030

3.91 × 10

-2

1.042

3.01 × 10

-7

PTPRD/
p23

1.30 × 10-7

0.972

4.75 × 10-3

9p24.1-

C. Summary of the meta-analysis of ‘IEC endometriosis’ and ‘UKB self-reported depression’ GWAS

rs6788293

1

rs6788293

3

13719848

T

C

0.952

2.81 × 10-8*

0.931

LINC00620/ 3p25.1

FE: Fixed effect; SNP: Single nucleotide polymorphism; Chr: Chromosome; EA: Effect allele; NEA: Non-effect allele; OR: Odds ratio. *RE2 model result reported (Table 3C)
due to the substantial heterogeneity (I Square = 84.59). Of the 34 independent SNPs (r2 < 0.6) reported in Table 3A, a total of 22 are independent from each other at r2 < 0.1
(lead SNPs). Using physical regions in LD with lead SNPs that were >250 kb from each other, 20 genomic loci were characterized from the 34 independent SNPs. Lead SNPs
within 250 kb of each other were merged into same locus; thus, the 22 lead SNPs were in 20 loci, with two genomic loci containing two lead SNPs each (Table 3A).
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Our functional annotation analysis using FUMA (see methods), identified a total of 2,372
candidate SNPs (independent SNPs as well as those in LD with them at r2 ≥ 0.6), and 22 lead
SNPs (genome-wide significant SNPs that are independent of one another at LD r2 < 0.1). Most
of the candidate SNPs were in the intergenic (66.30%), intronic (25.40%) and non-coding RNA
(4.91%) regions (Supplementary Fig. 1a, and Supplementary Table S4). As evidenced by
RegulomeDB scores having values less than two (Supplementary Fig. 1b and Supplementary
Table S4), a total of 75 SNPs (3.20% of candidate SNPs) has a high likelihood of a regulatory
function. Of the eleven exonic SNPs, six were synonymous while five were nonsynonymous
(Supplementary Fig. 1a, and Supplementary Table S4 and S5). Several of the SNPs had a
CADD score greater than 12.37 (Supplementary Fig. 1c) meaning they are potentially
pathogenic. The nonsynonymous exonic SNP having the highest CADD score (an indication
of strong deleterious effects) was rs1126809 (CADD score of 29.4). This SNP is located in
exon 4 of TYR on chromosome 11 and it is in strong LD with a lead SNP (rs7933594, r2 =
0.72), located at a genomic locus in LD with a depression index SNP (Table 3 and
Supplementary Table S4).
Using three methods of gene mapping strategies, implemented in FUMA—positional,
expression quantitative trait locus (eQTL), and chromatin interaction—we mapped the
candidate SNPs to genes (see methods). Additionally, we carried out GBGWAS on the same
set of SNPs using MAGMA software (implemented in FUMA). A total of 223 unique proteincoding genes was implicated, 20 of which were identified by all four methods (Supplementary
Fig. 2, Supplementary Table S6, S7 and S8). A total of 49 genes were implicated by positional

mapping, 73 by eQTL, and 217 by chromatin interaction mappings (Supplementary Fig. 2).
GBGWAS analysis identified a total of 24 genome-wide significant genes (Supplementary Fig.
2 and Supplementary Table S7 and S8). Furthermore, we characterized a total of 90
independent loci reaching genome-wide suggestive association (P < 1 × 10-5) in the crossdisorder meta-analysis of the IEC endometriosis and the PGC-UKB depression GWAS
(Supplementary Table S9).
Association between significant independent SNPs and other traits
Using PhenoScanner (v2), with an LD and significant threshold of r2 ≥ 0.6 and P < 5 × 10-8,
respectively (Staley et al. 2016), we assessed whether the independent genome-wide significant
SNPs identified in our meta-analysis were associated with other traits or conditions. Findings
revealed a genome-wide significant (P < 5 × 10-8) association with several traits
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(Supplementary Table S10). Notably, one of the independent significant SNPs, rs9835157
(hg19: chr3:49797769 A>G on chromosome 3p21.31) in IP6K1 (encoding inositol
hexakisphosphate kinase 1), was associated with several traits at a genome-wide significant
level (P < 5 × 10-8), including qualifications (college or university degree), age at menarche,
body mass index, pulse rate, impedance of the whole body, and overall health rating. One of
these traits (age at menarche) is a risk factor for endometriosis (Nnoaham et al. 2012) and
depression (Shen et al. 2019). Also, neuroticism (a possible risk factor for both endometriosis
and depression) (Nyholt et al. 2009; Xia et al. 2011) was associated with one of the SNPs
(rs62553458, hg19: chr9:11695224A>G). Lastly, rs13164188 (on chromosome5q21.2) was
associated at a genome-wide significant level with waist circumference, hearing difficulty, as
well as a doctor diagnosed ‘bronchitis, emphysema, asthma, rhinitis, eczema or allergy’.
Replication of identified loci
To test whether the independent loci reaching genome-wide significance in our meta-analysis
(for IEC endometriosis and PGC-UKB depression GWAS) can be replicated, we conducted
additional meta-analyses using the ‘PGC 2018 MDD excl23andMe’ and the ‘self-reported
depression UKB’ GWAS. Using the lead SNPs, we considered a locus reproduced when the P
value obtained in a cross-disorder meta-analysis (P [FE] or P [RE2]) is less than the respective P
value for each of endometriosis and depression GWAS. The P value for each of endometriosis
and depression GWAS must at the least be nominally significant (P < 0.05).
First, a meta-analysis of the ‘IEC endometriosis’ and the ‘PGC 2018 MDD excl23andMe’
reproduced 17 of the 20 independent loci at P < 0.05 (Supplementary Table S11). Although
none of the loci reached genome-wide significant association, seven of them (rs9586 on
chromosome 3p21.31, rs2134025 on 4q24, rs13164188 on 5q21.2, rs11561993 on 7q31.1,
rs11784932 on 8q24.21, rs1931391 on 9p24.1-p23, and rs13299293 on 9p21.1) were genomewide suggestive (P < 1 × 10-5, Supplementary Table S11). Also, additional four independent
loci reached a genome-wide level of significance in the replication analysis (Table 3B), all
(rs323509, rs1931388, rs116810322, rs1931388) of which have been identified in more
powerful depression GWAS to be genome-wide significant (Howard et al. 2019; Nagel et al.
2018).
Second, meta-analyzing the ‘IEC endometriosis’ and the ‘self-reported depression UKB’
GWAS, we similarly reproduced 6 of the 20 loci at P < 0.05. Of these, two loci (rs12121863
on chromosome 1q31.3, and rs9586 on 3p21.31) were at least genome-wide suggestive
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(Supplementary Table S12). Also, we identified an additional independent SNP locus shared
by both endometriosis and depression (Table 3C).
Results of causal associations assessment
Table 4 summarizes the results of our MR analyses assessing the causal association between
endometriosis and depression. Based on the IVW MR model (OR = 1.003, 95%CI: 0.967–
1.041, P = 0.866), MR did not find evidence of a significant causal relationship between
endometriosis (exposure variable) and depression (outcome variable). The results of our
sensitivity analysis using the weighted median (OR = 1.018, 95%CI: 0.979–1.059, P = 0.371)
and the MR Egger (OR = 1.134, 95%CI: 0.925–1.390, P = 0.258) models were consistent with
that of the IVW in this respect (Table 4). The MR-Egger intercept was -0.0123 (SE: 0.0104),
P = 0.262, which did not deviate significantly from zero, showing that there was no significant
directional or unbalanced pleiotropy. Also, given the Cochran’s Q statistics for IVW (Q =
17.23, degree of freedom, df = 10, P = 0.069) and MR-Egger (Q’ = 14.87, df = 9, P = 0.095),
there was no evidence for a significant heterogeneity. One of the SNPs (rs74485684) was
associated with menstruation-related traits (‘length of menstrual cycle’ and ‘excessive,
frequent and irregular menstruation’). However, a leave-one-out analysis indicates that
individual influential SNPs did not drive the observed results. A further assessment using the
MR-PRESSO method supports the IVW model. For instance, MR-PRESSO’s raw estimate was
similar to that of the IVW (Table 4). Also, the ‘global test’ found no significant horizontal
pleiotropy (global test P value = 0.0758) just as the ‘outlier test’ found no outlier SNPs.
In contrast, analysis for a causal influence of depression (exposure variable) on endometriosis
(outcome variable) using the IVW model provided evidence of a causal association between
the two traits (OR = 1.26, 95%CI: 1.046–1.51, P = 0.0149). A sensitivity assessment using the
weighted median model supports this finding (OR = 1.24, 95%CI: 1.012–1.55, P = 0.0447);
however, the MR-Egger method did not (OR = 1.069, 95%CI: 0.39–2.96, P = 0.8985). Given
the Egger intercept did not deviate significantly from zero (intercept = 0.0050, SE = 0.0157, P
= 0.7521), there was no evidence for unbalanced pleiotropy which would suggest that the IVW
estimates were unbiased. Also, the difference between Q and Q′ (Q - Q′ = 0.16) is not
sufficiently extreme under a

χ12

distribution, meaning, that the MR-Egger model was not a

better fit for our data compared to the IVW model. Nonetheless, there was evidence for a
significant heterogeneity (Q = 70.98, df = 46, P = 0.0105; and Q’ = 70.82, df = 45, P = 0.0083).
Hence, we performed MR-PRESSO test to detect pleiotropy (global test P value = 0.011) and
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exclude outlier variants. Our findings remain consistent with the IVW’s results even after
correcting outlier SNPs (Table 4). The ‘distortion test` P value was 0.60 which indicates that
there was no difference between causal estimates before and after outlier removal. Also, we
conducted a ‘leave-one-out’ MR analysis and the results remain consistent, showing that the
finding in the model was not driven by individual influential SNPs.
Importantly, we replicated the results for the significant causal effect of depression on
endometriosis using independent endometriosis and depression GWAS through the online
platform (MR-Base). The GWAS data ‘seen doctor (GP) for nerves anxiety tension or
depression’ (id: UKB-a:246) were utilized as the exposure variable and the ‘self-reported:
endometriosis’ (id: UKB-b:10903) as the outcome variable. The results on the IVW (Beta =
0.0209, SE, = 0.0060, P =0.000622), the IVW Radial (Beta = 0.0208, SE = 0.0058, P =
0.000394), and the weighted median (Beta = 0.0191, SE = 0.00875, P = 0.0291) models, were
consistent with our previous findings. Notably, the test for heterogeneity was not significant
(MR Egger Q’ = 16.58, df = 17, P = 0.483; and the IVW Q = 16.79, df = 18, P = 0.537). Also,
the MR-Egger intercept was -0.0001161 (SE = 0.000252, P = 0.651), which rules out
significant directional pleiotropy and lends further support for a causal influence of depression
on endometriosis.
Table 4 MR results for endometriosis and depression association
MR results of endometriosis (exposure) and depression (outcome)
OR

95%CI

P value

1.003

0.967–1.041

8.66 × 10-1

11

1.134

0.925–1.390

2.58 × 10-1

11

1.018

0.979–1.059

3.71 × 10-1

P value

S/N

Methods

1

IVW

No
SNPs
11

2

MR Egger

3

Weighted median

of

MR-PRESSO
Method

Causal estimates (Beta)

OR

Sd

T-stat

Raw

0.0032

1.003

0.019

0.168

Outlier
corrected

-

-

-

-

a

8.70 × 10-1

-

Global test P value = 0.0758

MR results of depression (exposure) and endometriosis (outcome)

1

IVW

47

1.26

1.046–1.510

1.49 × 10-2

2

MR Egger

47

1.07

0.390–2.960

8.99 × 10-1

3

Weighted median

47

1.24

1.012–1.550

4.47 × 10-2

OR

Sd

T-stat

P value

MR-PRESSO
Method

Causal estimates (Beta)
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Raw

0.229

1.257

Outlier
corrected

0.193

1.213

0.094
0.087

2.436
2.211

1.88 × 10-2
3.21 × 10-2

Global test P value = 0.0112

No: Number, CI: Confidence interval, OR: Odds ratio, MR: Mendelian Randomization, IVW: inverse-variance
weighted model, MR-PRESSO: Mendelian randomization pleiotropy residual sum and outlier, a: no outlier SNPs,
hence no results for outlier corrected analysis.

Gene-based association analyses results
MAGMA gene-based association analysis of the endometriosis and depression GWA data
produced results for 18,188 genes. Using a gene-based genome-wide significant threshold of
P < 2.75 × 10-6 (Bonferroni adjustment for testing 18,188 genes [0.05/18,188]), we identified
eight genes associated with endometriosis and 116 for depression (Supplementary Table S13).
We assessed genes overlapping the two traits at Pgene < 0.1, resulting in a total of 768 genes
(Supplementary Table S14). Using FCP (see method), we estimated the combined P values for
the overlapping endometriosis and depression genes (Supplementary Table S14). FCP results
reveal a total of 22 genes overlapping endometriosis and depression that reached a gene-based
genome-wide significant threshold of P < 2.75 × 10-6 (Table 5A). To replicate these 22 genes,
we utilized additional depression GWAS in performing FCP analysis. To be considered
replicated, a gene must at least be nominally significant for endometriosis (Pgene (endometriosis) <
0.05) and depression (Pgene (depression) < 0.05), and the FCP must be less than the respective gene
association P values for the two traits (i.e., [Pgene (endometriosis) < 0.05] > FCP < [Pgene (depression) <
0.05]).
Using the PGC MDD GWAS we reproduced 17 of the 22 genes (Supplementary Table S15)
three of which reached genome-wide significance (RP11-3B7.1, RHOA and CCDC71) for the
PGC MDD (Table 5B). Also, we identified three additional genome-wide significant genes
(C3orf84, BSN, LAMB2) in the replication analysis using the PGC MDD (Table 5B). Using the
self-reported UKB depression GWAS, we replicated seven of the 22 genes (CABP1, FOXP1,
UBA7, TRAIP, RNF123, RP11-3B7.1, and RHOA [borderline significance for the self-reported
UKB depression GWAS]), as summarized in Supplementary Table S16, none of which reached
genome-wide significance. However, two additional genes (NRG1, and KLHL18) reached
genome-wide significance (Table 5C).
Table 5 Genome-wide significant genes for endometriosis and depression
Genes

Chr

Start position
(hg19)

Stop position
(hg19)
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Endometriosis P
value

Depression P
value

FCP value

A. IEC endometriosis and PGC-UKB Depression
RFWD2

1

175913967

176176629

3.73 × 10-3

6.92 × 10-6

4.77 × 10-7

CCDC71

3

49199968

49203754

3.57 × 10-4

2.50 × 10-5

1.74 × 10-7

CCDC36

3

49235861

49295537

4.14 × 10

1.56 × 10

-5

1.28 × 10-7

RP11-3B7.1

3

49297518

49298744

1.22 × 10-4

6.02 × 10-6

1.62 × 10-8

RHOA

3

49396578

49450431

1.68 × 10-4

1.84 × 10-5

6.36 × 10-8

NICN1

3

49460379

49466759

8.49 × 10-4

4.33 × 10-6

7.51 × 10-8

DAG1

3

49506146

49573048

9.20 × 10

1.13 × 10

-4

1.78 × 10-6

MST1

3

49721380

49726934

5.10 × 10-4

2.04 × 10-4

1.78 × 10-6

RNF123

3

49726932

49758962

2.62 × 10-3

2.65 × 10-5

1.21 × 10-6

AMIGO3

3

49754267

49761349

1.47 × 10-2

7.69 × 10-6

1.92 × 10-6

GMPPB

3

49754277

49761384

1.47 × 10

7.69 × 10

-6

1.92 × 10-6

UBA7

3

49842640

49851379

4.06 × 10-3

1.02 × 10-5

7.45 × 10-7

TRAIP

3

49866034

49894007

2.46 × 10-3

1.94 × 10-5

8.52 × 10-7

FOXP1

3

71003844

71633140

2.13 × 10-4

1.54 × 10-4

5.99 × 10-7

FNIP2

4

159690290

159829201

4.17 × 10

3.26 × 10

-6

2.28 × 10-6

GABRA1

5

161274197

161326975

6.58 × 10-3

2.45 × 10-5

2.68 × 10-6

ESR1

6

151977826

152450754

3.15 × 10-5

3.66 × 10-3

1.96 × 10-6

ARL14EP

11

30344598

30359774

6.80 × 10-6

3.38 × 10-3

4.27 × 10-7

UBE4A

11

118230300

118269926

1.31 × 10

3.77 × 10

-6

8.83 × 10-7

ATP5L

11

118271869

118302211

2.67 × 10-2

3.98 × 10-6

1.81 × 10-6

CABP1

12

121078355

121105127

1.46 × 10-2

2.75 × 10-6

7.22 × 10-7

WIPI1

17

66417089

66453654

1.13 × 10-3

4.51 × 10-5

9.03 × 10-7

1.02 × 10-4
1.63 × 10-4
2.89 × 10-4
3.80 × 10-4
3.12 × 10-4
3.82 × 10-4

1.68 × 10-7
5.07 × 10-7
6.41 × 10-7
1.12 × 10-6
1.69 × 10-6
2.29 × 10-6

-4

-4

-2

-2

-2

B. IEC endometriosis and PGC-MDD
C3orf84
3
49215065
49229291
8.41 × 10-5
BSN
3
49591922
49708978
1.69 × 10-4
RP11-3B7.1 3
49297518
49298744
1.22 × 10-4
RHOA
3
49396578
49450431
1.68 × 10-4
LAMB2
3
49158547
49170551
3.16 × 10-4
CCDC71
3
49199968
49203754
3.57 × 10-4
C. IEC endometriosis and UKB self-reported depression
NRG1

8

31496902

32622548

1.55 × 10-4

4.11 × 10-4

1.12 × 10-6

KLHL18

3

47324407

47388306

2.71 × 10-2

3.41 × 10-6

1.59 × 10-6

Chr: Chromosome, IEC: International Endogene Consortium, PGC: Psychiatric Genomic Consortium, UKB:
United Kingdom Biobank, MDD: Major Depressive Disorder, FCP: Fishers Combined P value

Lastly, our independent gene-based analysis and binomial test confirmed that a significant
gene-level genetic overlap exists between endometriosis and depression (Table 6). For
example, the observed proportion (18.3%) of genes overlapping the two traits at Pgene < 0.05
was significantly higher (Pbinomial-test = 2.90 × 10-4) than the expected proportion (15.0%) (Table
6). A similar pattern of results was obtained for overlapping genes at Pgene < 0.01 (Pbinomial-test
= 1.32 × 10-4) and Pgene < 0.1 (Pbinomial-test = 1.31 × 10-5), providing further support for a highly
significant molecular genetic overlap between the two disorders (Table 6).
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Table 6 Summary of independent gene-based association analysis and gene-level genetic overlap between endometriosis and depression

The effective number of independent genes in endometriosis and depression
Disorder

Total genes
Rawc
Effectived

P value < 0.1
Rawc
Effectived

Proportione

P value < 0.05
Rawc
Effectived

Proportione

P value < 0.01
Rawc
Effectived

Proportione

Endometriosisa
Depressionb

20,225
20,225

2,954
4,769

0.144
0.227

1,729
3,194

0.084
0.150

473
1,428

0.023
0.064

17,331
17,223

2,494
3,909

1,450
2,576

393
1,109

Number of overlapping genes and binomial test results for gene-level genetic overlap
Discovery
Targets
Overlapping genes
Proportion of overlap
Binomial test p value
Raw
Effective
Expected
Observed
P value < 0.01
Endometriosis
Depression
62
45
1,109/17,223 = 0.064
45/393 = 0.115
1.32 × 10-4
P value < 0.05
Endometriosis
Depression
322
266
2,576/17,223 = 0.150
266/1450 = 0.183
2.90 × 10-4
P value < 0.1
Endometriosis
Depression
771
656
3,909/17,223 = 0.227
656/2494 = 0.263
1.31 × 10-5
a
b
Endometriosis data from International Endogene Consortium, Depression data from Psychiatric Genomics Consortium and United Kingdom Biobank (PGC-UKB), c Raw
number of genes (total number of genes obtained in the gene-based association analysis using VEGAS2 software), d Effective number of independent genes (the total number
of independent genes obtained in the independent gene-based test using the ‘genetic type 1 error calculator’ method), e Proportion of total effective number of independent
genes
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Gene-drug targets results
Our gene-drug interaction testing indicates that several of our input genes interact uniquely
with a range of different drugs (Supplementary Table S17). The types of interactions were
known for eight of the genes—ERBB4, CD3D, BLK, RARG, AURKB, POLE, FGFR1, HCK
(Supplementary Table S17). Notably, CD3D interacts with BLINATUMOMAB as an
‘activator’, while RARG interacts with ‘TRETINOIN’ as an agonist (Supplementary Table S17
and S18). Further, our search for potential druggable targets identified 11 genes with different
druggable characteristics (Supplementary Table S19). These include tumor suppressor (RHOA,
CCDC36), DNA repair (UBA7), serine-threonine kinase (RHOA, MST1), transporter and ABC
transporter (ATP5L, GABRA1) and ion channel (GABRA1), among others (Supplementary
Table S19).
Results of pathway-based functional enrichment analysis
Table 7 presents our findings for pathway-based functional enrichment analysis for genes
overlapping both endometriosis and depression at Pgene < 0.1 (Pbinomial-test = 1.31 × 10-5). A total
of seven genetically influenced biological pathways were significantly enriched including,
‘calcium-dependent cell-cell adhesion’ (P(adjusted) = 1.25 × 10-2), and ‘inositol phosphate
metabolism’ (P(adjusted) = 5.65 × 10-3). Others include ‘Hippo-Merlin Signaling Dysregulation’
(P(adjusted) = 2.75 × 10-2), ‘peptic ulcer’ (P(adjusted) = 1.61 × 10-3), and ‘hypoplastic toenails’
(P(adjusted) = 3.65 × 10-2). Further details about these pathways including genes implicated are
presented in Table 7. Notably, ‘pathways regulating Hippo Signaling’ (P(adjusted) = 2.52 × 10-5),
and ‘abnormality of the gastric mucosa’ (P(adjusted) = 1.23 × 10-4) produced the most statistically
significant enrichment. Given that several related or overlapping pathways may be significantly
enriched, we organized the overrepresented pathways found in the present study into clusters
based on their biological themes. This practice eliminates redundancy and enhances both the
visualization as well as the interpretation of significantly enriched pathways. We utilized the
‘auto-annotate’ software for this analysis, thereby identifying three clusters of pathways
implicated in the biology of both disorders (Fig. 1).
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Table 7 Significantly enriched pathways for endometriosis and depression
Pathway name

Pathway term
Id
Gene Ontology: Biological Process

Adjusted
P value

Genes

Calcium-dependent
cell-cell adhesion via
plasma membrane cell
adhesion molecules
Reactome

1.25 × 10-2

CDH13, CDH9, CDH22, PCDHB5, PCDHB4,
CDH8, PCDHGC3, PCDHB3, AJUBA,
CDH12

Inositol phosphate
REAC: R-HSAmetabolism
1483249
Biological Pathways: WikiPathways

5.65 × 10-3

IP6K1, PLCB3, INPP5A, IMPA1, PLCH1,
INPP5B, ISYNA1, PLCH2, MTMR9, INPPL1

Pathways Regulating
Hippo Signaling

2.52 × 10-5

CDH13, RHOA, MST1, CDH9, CDH22,
PRKCD, PLCB3, NTRK2, PRKAR2A, LATS1,
FGFR1, TCF7L1, CDH8, GNAI2, LATS2,
PRKAA2, CDH12
CDH13, MST1, LIN28B, CDH9, CDH22,
NTRK2, PRKAR2A, ITGB8, LATS1, FGFR1,
CDH8, LATS2, AJUBA, CDH12

GO: 0016339

WP: WP4540

Hippo-Merlin
WP: WP4541
2.75 × 10-2
Signaling
Dysregulation
Biological Pathways: Human Phenotype Ontology
Abnormality of the
gastric mucosa
Peptic ulcer

HP: 0004295

1.23 × 10-4

HP: 0004398

1.61 × 10-3

Hypoplastic toenails

HP: 0001800

3.65 × 10-2

ABCC2, PRKCD, GTF2I, ARID1B, CISD2,
CLIP2, ERGIC1, RASGRP1, LIMK1, WFS1
GTF2I, ARID1B, CISD2, CLIP2, ERGIC1,
LIMK1, WFS1, CDKN2C
SMARCE1, GTF2I, ARID1B, CLIP2, FGFR1,
EZH2, COL11A1, SHOC2, LIMK1, INPPL1

Fig. 1 Significantly enriched pathways for endometriosis and depression
Clustered biological themes of significantly enriched biological pathways for overlapping endometriosisdepression genes

‘Abnormality of gastric mucosa’ implicated in the biological mechanisms of both
endometriosis and depression, and, likely in their comorbidity, in the present study, came
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across as a noteworthy finding. Hence, using GWAS summary data, readily available in the
public domain, we carried out a follow-up analysis to examine the relationship between each
of endometriosis and depression and two of gastric mucosa-related disorders—
gastroesophageal reflux disease (GERD) and gastritis/duodenitis, respectively (see
Supplemental Note 2 for a comprehensive description of this assessment).
Our findings are summarized in Fig. 2. Briefly, LDSC regression analysis reveals a positive
and highly significant genetic correlation between endometriosis and GERD (rG = 0.24, P =
1.17 × 10-20) [Fig. 2]. There was also evidence for a positive and significant genetic correlation
between endometriosis and gastritis/duodenitis (rG = 0.18, P = 1.5 × 10-3) [Fig. 2]. Furthermore,
we found a strong, positive and highly significant genetic correlation between depression and
GERD (rG = 0.52, P = 1.96 × 10-145), as well as between depression and gastritis/duodenitis (rG
= 0.51, P = 3.21 × 10-14) [Fig. 2].
A further assessment using the IVW model in a “TwoSampleMR” analysis indicates no
evidence for a causal association when endometriosis was assessed as an exposure variable
against GERD as an outcome (Supplemental Note 2). Conversely, when we assessed GERD as
exposure and endometriosis as an outcome variable, we found a significant causal association
between the two traits (IVW OR = 1.30, P = 0.00653) [Fig. 2, and Supplementary Table S20].
There was no evidence for significant heterogeneity (MR Egger Q’ = 30.75, df = 22, P = 0.102;
and the IVW Q = 30.85, df = 23, P = 0.125). Also, the test for directional pleiotropy was not
significant (Egger intercept = 0.0078, SE = 0.0270, P = 0.773). Sensitivity analyses using the
‘weighted median’ model (close to border-line significance) and MR Egger models did not
support findings for IVW model in this instance (Supplemental Note 2 and Supplementary
Table S20). However, as indicated by the difference between Q and Q’, the MR-Egger model
was not a better fit for our data compared to the IVW (Supplementary Table S20). Importantly,
the MR-PRESSO results were consistent with those of the IVW model (global test P value =
0.137 [supporting evidence of no horizontal pleiotropy]; outlier test = no outlier variants; and
raw causal OR = 1.301, P = 0.0122). The leave-one-out analysis was similarly consistent
indicating that the association was not driven by individual influential SNPs.
In a related assessment, we found a highly significant bidirectional causal association between
depression and GERD (depression as an exposure variable versus GERD as an outcome
variable: OR = 1.56, P = 2.39 × 10-23; GERD as an exposure variable versus depression as an
outcome variable: OR =1.30, P = 3.66 × 10-9) [Fig. 2 and Supplementary Table S21]. Also, MR
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provides evidence for a causal association between depression and gastritis/duodenitis
(depression as an exposure variable versus gastritis/duodenitis as an outcome variable OR =
1.29, P = 0.000567) [Fig. 2 and Supplementary Table S22]. Sensitivity tests using the ‘weighted
median’ model support all results for the IVW model. Although the MR Egger model supports
IVW only in respect of depression (exposure variable) vs GERD (outcome variable), the MRPRESSO was consistent with the IVW model in all analyses (see Supplemental Note 2 and
Supplementary Table S22 for details).
Last, we did not find a significant causal association between endometriosis (as exposure
variable) and gastritis/duodenitis (as outcome variable) [IVW OR = 1.039, P = 0.35]
[Supplemental Note 2 and Supplementary Table S20]. No genome-wide significant SNP was
associated in gastritis/duodenitis GWAS summary data (violation of the first MR assumption),
hence further analysis—gastritis/duodenitis vs endometriosis and gastritis/duodenitis vs
depression—were not conducted. Taken together, our study implicates abnormal conditions of
gastric mucosa in the causal pathways of endometriosis and depression as summarized in Fig.
2.

Fig. 2 Associations between endometriosis, depression, GERD and gastritis/duodenitis
Path diagram summarizing the relationship (correlation and causal association) between endometriosis,
depression and two abnormal conditions of gastric mucosa (GERD and gastritis/duodenitis) found in our study.
GERD: gastroesophageal reflux disease. The dashed bidirectional arrowhead line describes correlation
relationships based on linkage disequilibrium score regression analyses (LDSC) results. rG: genetic correlation
obtained for the pairs of traits in the LDSC. P: P value. a: causal relationship between GERD (as the exposure)
and depression (as the outcome), odds ratio (OR) = 1.30, P = 3.66 × 10-9. b: causal relationship between depression
(as exposure) and GERD (as outcome), OR = 1.56, P = 2.39 × 10-23. c: causal relationship between depression (as
exposure) and endometriosis (as outcome), OR = 1.26, P = 1.49 × 10-2. d: causal relationship between GERD
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(exposure) and endometriosis (outcome), OR = 1.30, P = 6.53 × 10-3. e: causal relationship between depression
(exposure) and gastritis/duodenitis (outcome), OR = 1.29, P = 5.67 × 10-4.

Discussion
We assessed the comorbidity of endometriosis and depression using several statistical methods
and performing both SNP- and gene-level analyses. Well-powered GWAS summary data from
large research consortia were utilized for analysis. To our knowledge, this is the first study to
comprehensively assess the relationship between endometriosis and depression by analyzing
GWAS data. Findings from SECA and LDSC regression analyses indicate that a highly
significant SNP-level genetic overlap and correlation exist between endometriosis and
depression. For example, of the 1,844 independent SNPs associated with both endometriosis
and depression at P < 0.05 (SNP subset having P1 and P2 < 0.05, see methods), a total of 1,065
(57.8%) showed evidence of significant concordance effects (OR = 1.86, PFisher’s-exact = 4.72 ×
10-11) in SECA. Consolidating the findings for SECA, bivariate LDSC regression analysis
estimates a positive and highly significant genetic correlation between the two traits.
Traditional observational studies have reported conflicting findings for the co-occurrence of
endometriosis and depression (Cavaggioni et al. 2014; Chen et al. 2016; Gambadauro et al.
2019; Novais et al. 2018). However, the significant genetic overlap and correlation between
the two disorders found in our study confirm their comorbidity and indicate that, at the least, a
proportion of endometriosis and depression patients share similar genetic etiology. Supporting
this position, the independent gene-based test reveals the presence of a highly significant genelevel genetic overlap between endometriosis and depression. Our study was based on the
analysis of genotype data; hence, findings are reliable and are not likely to suffer from
methodological complications such as the bias of reverse causation or the confounding effects
of lifestyles and/or environments, unlike the traditional observational studies.
Leveraging on the power afforded by data pooling and our finding of highly significant genetic
overlap between endometriosis and depression, we meta-analyzed the respective GWAS
summary statistics to discover susceptibility loci shared by both traits. Notably, our crossdisorder GWAS meta-analysis identified 20 independent genomic loci reaching genome-wide
significance. Eight of the loci have not previously been reported for either endometriosis or
depression at a genome-wide significant level, indicating them to be novel risk loci. The
remaining twelve loci were either at or near a previously identified depression locus, and our
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study reveals their potential involvement in both disorders, and perhaps their comorbid state.
The identified novel SNPs and loci mapped to several genes including TNR, BRINP3,
CC2D2A, TACR3, C6orf118, GSDMC, PCDH17, and NR2F2. The TNR gene is predominantly
expressed in the brain and is involved in the focal adhesion pathway and microglia activation
in neuroinflammation (Anlar and Gunel-Ozcan 2012; Roll and Faissner 2019) which may
support the roles of the pathways (focal adhesion and neuroinflammation) in the pathogenesis
of endometriosis and depression. Indeed, the genomic region harboring this gene has been
implicated in some brain disorders like Alzheimer’s disease, schizophrenia, neurological sleep
disorder and narcolepsy (Zuo et al. 2012). NR2F2 is similarly expressed in the brain, but more
broadly in the ovary, endometrium, spleen as well as in several other tissues including the heart,
kidney and gastrointestinal organs like the stomach, colon, duodenum, and esophagus (Lin et
al. 2011). Pathogenic mutation in this gene has been implicated in cardiovascular disorders
including congenital heart defects (Al Turki et al. 2014; Wang et al. 2019).
We replicated many of the loci (identified in our meta-analysis) using separate depression
GWAS data, with some reaching genome-wide suggestive association—supporting evidence
of their involvement in both traits. We note that the ‘PGC_UKB depression’ (n = 500,199)
GWAS data, utilized in the initial meta-analysis, were better powered. Hence, it is not
surprising that the replication analyses, using the less powerful ‘PGC 2018 MDD
excl23andMe’ (n = 173,005) and ‘self-reported depression UKB’ (n = 289,307) GWAS, did
not replicate loci reaching a genome-wide significance unlike in the primary cross-disease
meta-analysis (for IEC endometriosis and the PGC_UKB depression GWAS). One of the more
noteworthy findings in our replication analyses is the potential for identifying robust SNPs and
loci, for endometriosis and depression, by meta-analyzing their respective GWAS data. For
example, the SNPs (rs116810322, rs6808036, rs1931388 and rs323509) we identified, were
genome-wide significant for depression in previous GWAS studies (Howard et al. 2019; Nagel
et al. 2018) but not in the ‘PGC 2018 MDD’ used for replication testing in the present study.
Following the meta-analysis of the ‘IEC endometriosis’ and the ‘PGC 2018 MDD’ GWAS, the
named SNPs attained genome-wide significance, supporting our premise, and confirming
evidence of shared genetics between endometriosis and depression.
We conducted MR analyses and our findings provided evidence of a causal association between
depression (as the exposure variable) and endometriosis (as the outcome variable). We
compared the results of the IVW model with three other MR methods (the weighted median,
the MR-Egger and the MR-PRESSO) since consistent estimates across the four models may
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strengthen evidence of a causal association. The MR-Egger method did not support the causal
effects of depression on endometriosis which may indicate sampling variations or a possible
violation of MR assumptions (Bowden and Holmes 2019). However, the weighted median
model was consistent with that of the IVW. In instances where most IVs are valid, the weighted
median method is known to be more precise than the MR-Egger model (Burgess and Thompson
2017), which may be the case in our study given the wide confidence interval of the MREgger’s result. Other assessments carried out indicate that MR assumptions were not violated.
For example, the Egger intercept was not significantly different from zero indicating that there
was no unbalanced pleiotropy. While there was evidence for heterogeneity, the MR-PRESSO
test excluded outlier SNPs and the results before and after outlier correction were consistent
with those of the IVW model. Notably, using independent GWAS data for the respective traits,
we replicated the causal effect of depression on endometriosis, in the online platform of MR
analysis (the MR-Base), with no evidence for directional pleiotropy or heterogeneity.
The biological mechanism underpinning the causal influence of depression on endometriosis
is, however, unclear; and to our knowledge, this is the first study to suggest this causal
relationship. The finding is, nonetheless, consistent with a recent longitudinal study which
found bidirectional associations between endometriosis and depressive disorders (Gao et al.
2020). A potential explanation for the relationship would be the likely roles of the immune
system and inflammatory pathways which have been implicated in depression. For example,
immune system dysregulation, in the central nervous system, may activate inflammatory
responses, and in a prolonged state, inhibits apoptosis, as well as alters DNA repairs (Chida et
al. 2008; Fedeles et al. 2015). These processes have been suggested in the relationship between
depression and cancer (Chida et al. 2008; Fedeles et al. 2015) and may be relevant in the present
findings given that inflammatory and immune system dysfunction have similarly been
implicated in endometriosis (Adewuyi et al. 2020; Ahn et al. 2015; Miller et al. 2017).
Moreover, higher levels of inflammatory and pro-inflammatory biomarkers including Creactive protein, tumor necrosis factor and interleukins have been associated with both
depression and endometriosis (Adewuyi et al. 2020; Kim et al. 2016), providing further support
for our findings.
Reversing the direction of our analysis, MR found no evidence for a causal relationship
between endometriosis (as an exposure variable) and depression (as an outcome variable). This
non-significant finding may be because of the fewer number of endometriosis SNPs available
as IVs which may have resulted in limited power to detect a causal association in MR. Hence,
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we cannot completely rule out the possibility of a causal effect of endometriosis on depression.
A re-assessment of this finding, when more genome-wide significant SNPs for endometriosis
are available, should clarify these results.
To complement our SNP-level analyses, we further assessed the relationship between
endometriosis and depression using gene-based association analyses. Gene-based analyses
have the potential to be more powerful over SNP-based analyses and may provide mechanistic
insights into the biology of complex diseases. Our analysis identified 22 genes with a combined
gene-based genome-wide significant P value for endometriosis and depression. A gene-drug
targets search revealed that some of these significant genes are known for crucial biological
roles including tumor suppression (RHOA, CCDC36), DNA repair (UBA7), transcription factor
binding (ESR1), transport activities (ATP5L, GABRA1) and ion channel functions (GABRA1).
Also, one of the genes, ARL14EP at the 11p14.1 locus, previously implicated in endometriosis,
and several female hormone-related traits (Adewuyi et al. 2020; Mbarek et al. 2016; Ruth et
al. 2016a; Ruth et al. 2016b; Sapkota et al. 2017), was associated with both endometriosis and
depression in the present study.
Drawing on the strength of a systematic literature review and meta-analysis of cross-sectional
studies, a recent study has suggested that chronic pain largely explains endometriosis and
depression association (Gambadauro et al. 2019). Evidence that pain is often associated with
both endometriosis and depression (Bair et al. 2003; Demyttenaere et al. 2007; Facchin et al.
2015; Holmes et al. 2013; Sheng et al. 2017) may support its potential role in the two disorders,
and possibly in their co-occurrence. Also, our study, implicating genes involved in
inflammatory or neuroinflammatory processes (e.g., TNR and NF2) (Anlar and Gunel-Ozcan
2012; Omoigui 2007; Roll and Faissner 2019), in both endometriosis and depression,
potentially suggests a role for pain, since inflammation and inflammatory response underlie
the origin of pain (Omoigui 2007). Moreover, inflammatory mediators including interferongamma (IFN-γ), interleukin, and tumor necrosis factor-alpha (TNF-α) are parts of the
mechanisms represented by the hippo signalling pathways (Zhou et al. 2018) identified in our
study.
We note, however, that our study does not support pain (or chronic pain) as the determinant of
the association between endometriosis and depression, in the classic or suggested way of pain
in endometriosis leading to depression (i.e., depressed due to being in pain). While
Gambadauro and colleagues’ meta-analysis suggested that ‘chronic pain, rather than
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endometriosis itself, is the main determinant of depressive symptoms’ (Gambadauro et al.
2019, pp238), the present study indicates that both endometriosis and depression share similar
genetic etiology. First, genetic overlap assessment supports evidence of shared genetic
susceptibility for both disorders. Indeed, we identify SNPs, genes and loci shared by both
disorders. Second, our MR analysis suggests a causal relationship between endometriosis and
depression and the direction of causation indicates endometriosis as the outcome. Last, the use
of genotype data (as done in the present study) means the inheritance of shared genetic variants
for the two traits preceded lifestyle and environmental exposures which would negate the
suggestion that endometriosis-induced pain explains comorbid depression.
For further insight into the underlying biology of endometriosis and depression, we performed
pathway-based functional enrichment analysis and identified seven genetically influenced
biological pathways and processes shared by the two traits. For ease of visualization or
interpretation, the identified pathways were grouped into three broad themes and clusters: ‘cell
adhesion hippo signaling’, ‘inositol phosphate metabolism’ and ‘abnormality of gastric
mucosa’ significantly enriched for endometriosis and depression. The first cluster, cell
adhesion hippo signaling, comprises three pathways: ‘hippo-merlin signaling dysregulation’,
‘pathways regulating hippo signaling’ and ‘calcium-dependent cell-cell adhesion’. Merlin is a
multifunctional protein that integrates as well as regulates both extra- and intracellular
signaling pathways maintaining cell size, motility, shape and survival (Stamenkovic and Yu
2010). The protein is encoded by the NF2 gene and known to be a tumor suppressor
(Stamenkovic and Yu 2010).
Hippo signaling pathway, also known to be a tumor suppressor, ensures a balance between
apoptosis and cell proliferation, and it is activated and regulated by merlin (Li et al. 2015;
Stamenkovic and Yu 2010). Dysregulation of this pathway is believed to contribute to
decreased apoptosis and increased cell proliferation. Evidence similarly indicates that merlin
regulates cell-cell and cell-matrix adhesion (Stamenkovic and Yu 2010). Furthermore, inositol
phosphate metabolism pathway is critical to several physiological activities including
apoptosis, endocytosis, cell migration or proliferation, vesicle trafficking, PI3K/Akt and insulin
signalling (Tan et al. 2015). The dysregulation of this pathway has been noted in cancers (Tan
et al. 2015). The recognition that endometriosis sometimes behaves as a tumor (Guo 2018)
may, thus, be consistent with the dysregulation of the hippo-merlin as well as the inositol
phosphate metabolism pathways. In support of our findings, hippo signaling pathways have
been implicated in endometriosis (Song et al. 2016). In the case of depression, we do not have
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previous evidence implicating the ‘hippo-merlin-cell-adhesion’ signaling pathways; however,
mechanisms represented by those, for example, apoptosis, inflammation and cell proliferation
have been reported in depression (McKernan et al. 2009; Shelton et al. 2011; Zhou et al. 2018).
‘Gastric mucosa abnormality’ emerged as one of the most significantly enriched findings in
our pathway-based analysis. A follow-up study indicates the presence of a strong and highly
significant genetic correlation between each of endometriosis and depression, and the
respective ‘gastric mucosa abnormality’ traits, GERD and gastritis/duodenitis, assessed in the
follow-up analysis. These findings are not only consistent with previous observational evidence
(Choi et al. 2018; Haug et al. 2002; Kvaskoff et al. 2015; Parazzini et al. 2017; Roman et al.
2012), they confirm a comorbid relationship between the respective pairs of the disorders—
endometriosis and GERD, endometriosis and gastritis/duodenitis, depression and GERD, and
depression and gastritis/duodenitis. This would mean that both endometriosis and depression
share some genetic predisposition with GERD, gastritis/duodenitis and by extension, peptic
ulcer disease, implicating shared genetically determined mechanisms underlying their
association.
The exact biological mechanism(s) underlying the roles of gastric mucosa in the pathobiology
of endometriosis and depression, remains unclear. However, the effects of certain immune
system and inflammatory mediators—interferon-gamma (IFN-γ), interleukin, and tumor
necrosis factor-alpha [TNF-α] (Altomare et al. 2013; Kim et al. 2018)—may be a likely
explanation. These mediators are highly concentrated in the gastric or esophageal mucosa of
patients suffering an associated disorder, and are believed to up-regulate inflammatory
responses in the central nervous system which may predispose to depression (Altomare et al.
2013; Berk et al. 2013; Lampa et al. 2012). In the same vein, a comorbid relationship has been
reported between endometriosis and gastrointestinal symptoms (Parazzini et al. 2017). Given
that inflammation has long been associated with both endometriosis and depression (Berk et
al. 2013), this position supports current findings. Moreover, abnormal conditions of gastric
mucosa (GERD, gastritis, peptic ulcer disease), implicated in our study, have inflammatory
components. Thus, ‘gastric mucosa abnormality’ may represent an important link in the causal
pathways of endometriosis and depression and probably in the comorbid state of the two
disorders.
A further assessment using the MR analysis suggests causal associations of both endometriosis
and depression with at least one of GERD and/or gastritis/duodenitis. We found a causal effect
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of GERD on endometriosis as well as a bidirectional causal relationship between depression
and GERD. The finding for depression and GERD agrees not only with a previous
observational study (Kim et al. 2018) but also a recent GWAS analysis (Wu et al. 2019). Hence,
causality may indeed explain the comorbidity of depression with GERD. On the other hand,
while no previous study has reported a causal influence of GERD on endometriosis,
observational evidence supports a comorbid relationship between endometriosis and several
gastrointestinal disorders (Parazzini et al. 2017). Thus, gastric mucosa disorders may be a basis
for the co-occurrence of endometriosis and depression. It is logical to suggest that the
relationship between endometriosis and gastric mucosa traits could be due to the ulcerogenic
tendencies of non-steroidal anti-inflammatory drugs commonly used in the treatment of
endometriosis-associated pain. However, given the use of genotype data and the direction of
causality (endometriosis as the outcome) found in our study, such a suggestion will not be
consistent with the present study.
Taken together, we hypothesize that, abnormal conditions of gastric mucosa (e.g., GERD,
gastritis and peptic ulcer) are causal risk factors for endometriosis. The role(s) of these risk
factors may be through the direct causal effect or a link with depression or by mediating the
relationship between comorbid endometriosis and depression. Further, we propose that
effective treatment of underlying GERD (and other gastric mucosal abnormality traits
including peptic ulcer disease) may be of therapeutic relevance in comorbid endometriosis.
Recent observational studies suggest improved outcomes for endometriosis and
gastrointestinal symptoms following dietary considerations (Borghini et al. 2020; Moore et al.
2017). At the end of a three-month administration of a low nickel diet, there was a significant
improvement for endometriosis and gastrointestinal-like symptoms (Borghini et al. 2020). A
similar finding has been reported for a low FODMAP (fermentable oligosaccharides,
disaccharides, monosaccharides and polyols) diet (Moore et al. 2017). Thus, dietary approaches
may be potentially beneficial in comorbid endometriosis and depression. Further investigation
of the approach, for example, using randomized control trials, may be warranted in the context
of the present study.
Conversely, non-steroidal anti-inflammatory drugs are first-line pharmacological agents for
endometriosis-associated pain (Giudice 2010; Schwartz et al. 2020). These medications are
contra-indicated (or at the least should be used with caution) in GERD, gastritis, peptic ulcer
and indeed all conditions involving a compromised state of the gastric mucosa (Drini 2017).
Also, certain proton pump inhibitors (medications for managing GERD, gastritis, and peptic
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ulcer) have been associated with depression risk (Huang et al. 2018; Laudisio et al. 2018).
Hence, as a matter of diagnostic and treatment practices, there is a need for thorough symptom
investigations to rule out comorbid gastric mucosa abnormal conditions and depression before
initiating these medications.
Strengths and Limitations
The use of multiple statistical methods means a comprehensive, complementary, and balanced
assessment of the subject matter and represents a major strength of the present study. Unlike
the conventional observational studies, which are prone to the bias of reverse causation and
confounding effects of environments or lifestyles, our study is generally not susceptible to these
limitations given it was based on the analysis of genotype data. Accordingly, our findings
provide current and robust evidence on the co-occurrence of endometriosis and depression by
analyzing GWAS data. Nonetheless, it is important to consider some limitations in interpreting
findings in the present study.
First, the bias of sample overlap is likely between depression and GERD in our follow-up study
since the depression and GERD GWAS data were both partly sourced from the UK Biobank.
Such sample overlap is, however, unlikely to have affected our LDSC regression findings since
we did not constrain any of the intercepts involving depression GWAS (in the follow-up
analysis). Also, our MR analysis is not likely to have produced a biased conclusion given the
consistency of its findings with previous observational studies and a recent GWAS-based
analysis (Kim et al. 2018; Wu et al. 2019). Second, our study was based on the analysis of data
from mainly European ancestry, hence, readers need to exercise caution in generalizing
findings to other ancestries. Last, some of the significantly enriched pathways/mechanisms in
the pathway-based functional enrichment study could be redundant, thus, we collapsed related
pathways into simplified themes/clusters using enrichment mapping and auto-annotation
methods thereby enhancing the interpretation and visualization of our results.
Conclusions
Our study provides strong evidence for the co-occurrence of endometriosis and depression,
indicating that the two traits share similar genetic etiology. We identified 20 genome-wide
significant independent genomic loci, eight of which are novel, and 22 genome-wide
significant genes shared by both disorders. Also, we demonstrated a causal influence of
depression on endometriosis and identified three clusters of biological pathways for the two
traits (‘cell adhesion hippo signaling’, ‘abnormality of gastric mucosa’ and ‘inositol phosphate
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metabolism’). These pathways potentially implicate biological processes such as cell
proliferation, apoptosis, cell adhesion, as well as the possible roles of the immune system and
inflammatory mediators including interferon-gamma (IFN-γ), interleukin, and tumor necrosis
factor-alpha (TNF-α). Notably, gastric mucosa disorder traits were implicated in the causal
pathways of both endometriosis and depression. Our study, thus, highlights the importance of
screening for endometriosis among women presenting with depression and gastric mucosa
abnormality traits including GERD, gastritis, duodenitis, and peptic ulcer disease and vice
versa. Genes and pathways identified in our study could serve as potential druggable targets
for endometriosis and depression and especially the comorbid state of the two disorders. We
propose, given the novelty of our findings, that effective treatments for gastric mucosa diseases
or depression may find relevant therapeutic benefits for improved outcomes in comorbid
endometriosis. Also, we suggest possible benefits of dietary approaches in comorbid
endometriosis and depression given their association with gastric mucosal abnormalities.
Future studies using prospective follow-up or randomized control trial designs will need to
assess these proposals.
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